The London School of Hygiene & Tropical Medicine
The London School of Hygiene & Tropical Medicine is an organisation which uses OpenSAFELY to deliver research projects.
Projects
OpenSAFELY projects started by The London School of Hygiene & Tropical Medicine
-
Absolute Risks
1 user
1 workspace
-
Anticoagulant
1 user
6 workspaces
-
Association between ursodeoxycholic acid and COVID-19 outcomes
3 users
2 workspaces
-
Cardiovascular outcomes post-COVID-19 and the potential for COVID-19 vaccines to mitigate them
1 user
0 workspaces
-
Carehomes
1 user
7 workspaces
-
Carehomes Mortality
1 user
1 workspace
-
Carehomes Short Data Reports
2 users
2 workspaces
-
Carehome vs Non-Carehome Deaths
1 user
1 workspace
-
Comparing Disparities in RSV, Influenza and Covid-19
5 users
1 workspace
-
coronavirus pandemic on rheumatoid arthritis care and non-COVID outcomes
1 user
1 workspace
-
COVID-19 Collateral
6 users
4 workspaces
-
COVID-19 Collateral (Project continuation of approved project no 95)
6 users
2 workspaces
-
COVID-19 vs Non-COVID-19 Deaths
1 user
1 workspace
-
Descriptive cohort analysis of Long COVID and vaccination status
1 user
1 workspace
-
Effectiveness and safety of COVID-19 treatments for hospitalised patients
8 users
1 workspace
-
Effectiveness of sotrovimab/molnupiravir use vs non-use (Project continuation of approved project no 115)
1 user
0 workspaces
-
Effectiveness safety sotrovimab molnupiravir
4 users
3 workspaces
-
Effect of pre-exposure use of hydroxychloroquine on COVID-19 death in patients with rheumatoid arthritis or systemic lupus erythematosus
1 user
1 workspace
-
Ethnicity
1 user
8 workspaces
-
Evaluating the UK ‘shielding’ policy during the COVID-19 pandemic
3 users
1 workspace
-
Evaluating the UK ‘shielding’ policy during the COVID-19 pandemic (Project continuation of approved project no 150)
3 users
0 workspaces
-
Expected Background Rates of Clinical Events in Immunocompromised Patients
3 users
0 workspaces
-
Explaining the differential severity of COVID-19 between Indians in India and the UK (Project continuation of approved project no 101)
3 users
0 workspaces
-
Exploring quality and completeness of ethnicity recording in TPP, EMIS and linked data sources
2 users
0 workspaces
-
Healthcare needs for people with chronic kidney disease in the COVID-19 era
1 user
1 workspace
-
Healthcare needs for people with chronic kidney disease in the COVID-19 era (Project continuation of approved project no 137)
2 users
1 workspace
-
HIV infection and COVID-19 related death
1 user
1 workspace
-
Households
4 users
3 workspaces
-
Indians in India and the UK
3 users
1 workspace
-
Inhaled corticosteroids and risk of COVID-19 death
2 users
1 workspace
-
Learning Difficulties
1 user
2 workspaces
-
Lone households and mental health
3 users
1 workspace
-
long-covid-symptoms
3 users
1 workspace
-
Long-term complications after SARS-CoV-2 infection in relation to dialysis and kidney transplantation
1 user
0 workspaces
-
Long-term kidney outcomes after SARS-CoV-2 infection
2 users
2 workspaces
-
Long-term kidney outcomes after SARS-CoV-2 infection (Project continuation of approved project no 78)
2 users
0 workspaces
-
Non-Specific Immunity
1 user
2 workspaces
-
OpenPROMPT
7 users
2 workspaces
-
Post-COVID-19 Outcomes
2 users
3 workspaces
-
Post-COVID-19 Re-admissions
2 users
2 workspaces
-
Predictors of asymptomatic versus symptomatic infection with SARS-CoV-2
2 users
0 workspaces
-
Risk factors for COVID-19 disease progression in immunocompromised populations
2 users
1 workspace
-
Risk factors for COVID-19 disease progression in immunocompromised populations (Project continuation of approved project no 139)
5 users
0 workspaces
-
Risk of severe COVID-19 outcomes associated with atopic eczema and dupilumab
0 users
0 workspaces
-
Risk Prediction
3 users
1 workspace
-
School Age Children
2 users
4 workspaces
-
second-line-diabetes
1 user
1 workspace
-
SGTF CFR
1 user
3 workspaces
-
SGTF-Omi
1 user
1 workspace
-
Short-term safety of COVID-19 vaccines in England 2020/21 – acute venous thromboembolic events
1 user
2 workspaces
-
The effect of Long COVID on Quality Adjusted Life Years using OpenPROMPT
5 users
1 workspace
-
The healthcare utilisation of people with long COVID - OpenPROMPT
3 users
1 workspace
-
Type 1 Diabetes Mellitus
3 users
3 workspaces
-
Understanding and adjusting for bias in OpenSAFELY COVID testing data
6 users
3 workspaces
-
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19
3 users
1 workspace
-
Vaccine Neurological Safety
3 users
2 workspaces